Estrogen receptor expression in posterior tibial tendon dysfunction: A pilot study

Jay T. Bridgeman, Yue Zhang, Henry Donahue, Allison M. Wade, Paul Juliano

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Background: The pathophysiology of posterior tibial tendon dysfunction (PTTD) is poorly understood. It has been theorized that changes in hormone physiology may be a factor influencing tendon health. Estrogen's influence on the fibroblast has been studied in other musculoskeletal tissues. Gender differences in anterior cruciate ligament (ACL) injuries have been studied and it has been discovered that the Estrogen receptor (ER) as well as Progesterone receptor (PR) are expressed in the ACL. Material and Methods: Eight patients with PTTD requiring surgery were enrolled in our pilot study. The mean patient age was 52.4 (range, 18 to 73) years. There were five female and three male patients. Tendon samples were harvested from diseased PTT. Tendon samples harvested from healthy PTT and healthy flexor digitorum longus (FDL) tendon were used as controls. Tendon samples were processed using specific protocols for total RNA isolation from hypocellular, dense connective tissues. ERα and ERβ transcripts were quantified using real time RT-PCR. Quantitative values were obtained from the threshold cycle (Ct) number at which the increase in fluorescent signal associated with an exponential increase of PCR products can be detected. Results: Transcripts of both ERα and ERβ were reproducibly detected in RNA samples isolated from our tendon samples. There was no difference in receptor expression between diseased and control tendon samples. There was no difference in receptor expression between male and female patients. Conclusion: We found that the tenocyte of the PTT and FDL tendons express ERα and ERβ. Normal and diseased tendons of both male and female patients expressed both estrogen receptors. Clinical Relevance: Identifying ERα and ERβ gene expression in the fibroblast was an initial step in discovering whether tenocytes are targets for estrogen function. Estrogen receptors were identified indirectly by measuring receptor gene expression but we were unable to show a significant difference between diseased and control tendons.

Original languageEnglish (US)
Pages (from-to)1081-1084
Number of pages4
JournalFoot and Ankle International
Volume31
Issue number12
DOIs
StatePublished - Dec 1 2010

Fingerprint

Posterior Tibial Tendon Dysfunction
Estrogen Receptors
Tendons
Estrogens
Fibroblasts
RNA
Gene Expression
Anterior Cruciate Ligament
Progesterone Receptors
Connective Tissue

All Science Journal Classification (ASJC) codes

  • Surgery
  • Orthopedics and Sports Medicine

Cite this

Bridgeman, Jay T. ; Zhang, Yue ; Donahue, Henry ; Wade, Allison M. ; Juliano, Paul. / Estrogen receptor expression in posterior tibial tendon dysfunction : A pilot study. In: Foot and Ankle International. 2010 ; Vol. 31, No. 12. pp. 1081-1084.
@article{3fe767b8d03243b3bc3e97fdeb206865,
title = "Estrogen receptor expression in posterior tibial tendon dysfunction: A pilot study",
abstract = "Background: The pathophysiology of posterior tibial tendon dysfunction (PTTD) is poorly understood. It has been theorized that changes in hormone physiology may be a factor influencing tendon health. Estrogen's influence on the fibroblast has been studied in other musculoskeletal tissues. Gender differences in anterior cruciate ligament (ACL) injuries have been studied and it has been discovered that the Estrogen receptor (ER) as well as Progesterone receptor (PR) are expressed in the ACL. Material and Methods: Eight patients with PTTD requiring surgery were enrolled in our pilot study. The mean patient age was 52.4 (range, 18 to 73) years. There were five female and three male patients. Tendon samples were harvested from diseased PTT. Tendon samples harvested from healthy PTT and healthy flexor digitorum longus (FDL) tendon were used as controls. Tendon samples were processed using specific protocols for total RNA isolation from hypocellular, dense connective tissues. ERα and ERβ transcripts were quantified using real time RT-PCR. Quantitative values were obtained from the threshold cycle (Ct) number at which the increase in fluorescent signal associated with an exponential increase of PCR products can be detected. Results: Transcripts of both ERα and ERβ were reproducibly detected in RNA samples isolated from our tendon samples. There was no difference in receptor expression between diseased and control tendon samples. There was no difference in receptor expression between male and female patients. Conclusion: We found that the tenocyte of the PTT and FDL tendons express ERα and ERβ. Normal and diseased tendons of both male and female patients expressed both estrogen receptors. Clinical Relevance: Identifying ERα and ERβ gene expression in the fibroblast was an initial step in discovering whether tenocytes are targets for estrogen function. Estrogen receptors were identified indirectly by measuring receptor gene expression but we were unable to show a significant difference between diseased and control tendons.",
author = "Bridgeman, {Jay T.} and Yue Zhang and Henry Donahue and Wade, {Allison M.} and Paul Juliano",
year = "2010",
month = "12",
day = "1",
doi = "10.3113/FAI.2010.1081",
language = "English (US)",
volume = "31",
pages = "1081--1084",
journal = "Foot and Ankle International",
issn = "1071-1007",
publisher = "AOFAS - American Orthopaedic Foot and Ankle Society",
number = "12",

}

Estrogen receptor expression in posterior tibial tendon dysfunction : A pilot study. / Bridgeman, Jay T.; Zhang, Yue; Donahue, Henry; Wade, Allison M.; Juliano, Paul.

In: Foot and Ankle International, Vol. 31, No. 12, 01.12.2010, p. 1081-1084.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Estrogen receptor expression in posterior tibial tendon dysfunction

T2 - A pilot study

AU - Bridgeman, Jay T.

AU - Zhang, Yue

AU - Donahue, Henry

AU - Wade, Allison M.

AU - Juliano, Paul

PY - 2010/12/1

Y1 - 2010/12/1

N2 - Background: The pathophysiology of posterior tibial tendon dysfunction (PTTD) is poorly understood. It has been theorized that changes in hormone physiology may be a factor influencing tendon health. Estrogen's influence on the fibroblast has been studied in other musculoskeletal tissues. Gender differences in anterior cruciate ligament (ACL) injuries have been studied and it has been discovered that the Estrogen receptor (ER) as well as Progesterone receptor (PR) are expressed in the ACL. Material and Methods: Eight patients with PTTD requiring surgery were enrolled in our pilot study. The mean patient age was 52.4 (range, 18 to 73) years. There were five female and three male patients. Tendon samples were harvested from diseased PTT. Tendon samples harvested from healthy PTT and healthy flexor digitorum longus (FDL) tendon were used as controls. Tendon samples were processed using specific protocols for total RNA isolation from hypocellular, dense connective tissues. ERα and ERβ transcripts were quantified using real time RT-PCR. Quantitative values were obtained from the threshold cycle (Ct) number at which the increase in fluorescent signal associated with an exponential increase of PCR products can be detected. Results: Transcripts of both ERα and ERβ were reproducibly detected in RNA samples isolated from our tendon samples. There was no difference in receptor expression between diseased and control tendon samples. There was no difference in receptor expression between male and female patients. Conclusion: We found that the tenocyte of the PTT and FDL tendons express ERα and ERβ. Normal and diseased tendons of both male and female patients expressed both estrogen receptors. Clinical Relevance: Identifying ERα and ERβ gene expression in the fibroblast was an initial step in discovering whether tenocytes are targets for estrogen function. Estrogen receptors were identified indirectly by measuring receptor gene expression but we were unable to show a significant difference between diseased and control tendons.

AB - Background: The pathophysiology of posterior tibial tendon dysfunction (PTTD) is poorly understood. It has been theorized that changes in hormone physiology may be a factor influencing tendon health. Estrogen's influence on the fibroblast has been studied in other musculoskeletal tissues. Gender differences in anterior cruciate ligament (ACL) injuries have been studied and it has been discovered that the Estrogen receptor (ER) as well as Progesterone receptor (PR) are expressed in the ACL. Material and Methods: Eight patients with PTTD requiring surgery were enrolled in our pilot study. The mean patient age was 52.4 (range, 18 to 73) years. There were five female and three male patients. Tendon samples were harvested from diseased PTT. Tendon samples harvested from healthy PTT and healthy flexor digitorum longus (FDL) tendon were used as controls. Tendon samples were processed using specific protocols for total RNA isolation from hypocellular, dense connective tissues. ERα and ERβ transcripts were quantified using real time RT-PCR. Quantitative values were obtained from the threshold cycle (Ct) number at which the increase in fluorescent signal associated with an exponential increase of PCR products can be detected. Results: Transcripts of both ERα and ERβ were reproducibly detected in RNA samples isolated from our tendon samples. There was no difference in receptor expression between diseased and control tendon samples. There was no difference in receptor expression between male and female patients. Conclusion: We found that the tenocyte of the PTT and FDL tendons express ERα and ERβ. Normal and diseased tendons of both male and female patients expressed both estrogen receptors. Clinical Relevance: Identifying ERα and ERβ gene expression in the fibroblast was an initial step in discovering whether tenocytes are targets for estrogen function. Estrogen receptors were identified indirectly by measuring receptor gene expression but we were unable to show a significant difference between diseased and control tendons.

UR - http://www.scopus.com/inward/record.url?scp=78650364948&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650364948&partnerID=8YFLogxK

U2 - 10.3113/FAI.2010.1081

DO - 10.3113/FAI.2010.1081

M3 - Article

C2 - 21189209

AN - SCOPUS:78650364948

VL - 31

SP - 1081

EP - 1084

JO - Foot and Ankle International

JF - Foot and Ankle International

SN - 1071-1007

IS - 12

ER -